Medlab Clinical Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 0.011028 million compared to AUD 0.561015 million a year ago. Revenue was AUD 0.066349 million compared to AUD 2.42 million a year ago.

Net loss was AUD 1.98 million compared to AUD 4.82 million a year ago. Basic loss per share from continuing operations was AUD 0.87 compared to AUD 2.11 a year ago. Diluted loss per share from continuing operations was AUD 0.87 compared to AUD 2.11 a year ago.